Skip to content

ARTBIO vs MaaT Pharma

ARTBIO logo

ARTBIO

Channeling Energy. Changing Lives

74 employees · est. 2021 · Cambridge, United States

VS
MaaT Pharma logo

MaaT Pharma

Boosting Survival Through Innovative Immune Modulation

83 employees · est. 2014 · Lyon, France

MaaT Pharma is the older company (2021 vs 2014).

Side-by-Side Comparison

ARTBIO MaaT Pharma
Founded
2021 2014 older
Headquarters
Cambridge, United States Lyon, France
Employees
74 83
Industry
Biotechnology, Health Care, Medical Devices Biotechnology, Health Care
Funding Stage
Series B IPO
Total Funding
$245.00M $161.09M
Funding Rounds
3 12
Services
Development of Alpha Radioligand Therapies, Clinical Research and Trials, Manufacturing Ecosystem for Therapy Solutions Microbiome Ecosystem Therapies, AI-Powered Drug Development, cGMP Manufacturing, Immune Modulation for Cancer
Target Customers
Cancer Patients, Oncologists, Healthcare Providers Cancer Patients, Healthcare Professionals, Investors, Scientific Community
Taxonomy
Alpha Radioligand TherapiesRadiopharmaceuticalsClinical-stageCancer CarePrecision MedicinePb-212 Isotope Technology +6 Microbiome-driven TherapiesImmune ModulationOncologyGut MicrobiomeMicrobiota SymbiosisCancer Patient Survival +8
Website
artbio.com maatpharma.com
ARTBIO logo

About ARTBIO

ARTBIO, founded in 2021 and based in the United States, is pioneering a paradigm shift in cancer treatment. Their focus on developing Alpha Radioligand Therapies (ARTs) leverages unique Pb-212 isotope technology, aiming to offer transformative solutions in oncology. The company’s mantra, “Channeling...

MaaT Pharma logo

About MaaT Pharma

MaaT Pharma, a Lyon-based biotechnology firm established in 2014, is a trailblazer in developing innovative gut microbiome-driven therapies for immunomodulation in oncology. With the slogan "Boosting Survival Through Innovative Immune Modulation", the company is dedicated to enhancing cancer patient...

Also comparing in this category

Comparing more than these two?

Get ARTBIO, MaaT Pharma and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does ARTBIO compare?

A PDF of ARTBIO and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

ARTBIO was founded in 2021, based in Cambridge, United States, with 74 employees. ARTBIO, founded in 2021 and based in the United States, is pioneering a paradigm shift in cancer treatment. Their focus on developing Alpha Radioligand Therapies (ARTs) leverages unique Pb-212 isotope. MaaT Pharma was founded in 2014, based in Lyon, France, with 83 employees. MaaT Pharma, a Lyon-based biotechnology firm established in 2014, is a trailblazer in developing innovative gut microbiome-driven therapies for immunomodulation in oncology. With the slogan "Boosting.
ARTBIO has raised $245.00M and MaaT Pharma $161.09M. Latest stage: ARTBIO Series B, MaaT Pharma IPO.
Both work in Biotechnology and Health Care and list oncology among their focus areas.

Compare ARTBIO with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at ARTBIO on 9 Jun 2026, and MaaT Pharma on 1 Dec 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout